Illuminating the Way for Ethical, Cooperative and Efficient Pre-Approval Access in Unchartered Territory 

Join us at the second annual Pre-approval Access Programs Summit to reconvene with major topic influencers and be a part of the plan the future of Pre-Approval. Pharmaceutical and biotech executives, patient advocates, regulators and academia combine forces to create an all-encompassing program spotlighting each perspectives’ most challenging road blocks yielding standards and procedures you can look to for guidance. 

We dive back into the most polarizing topics such as patient consent, right-to-try and what these programs mean for your adverse event data and continue to trail blaze program structures for newcomers looking to provide these potentially life-saving solutions.  Faster processes, less paperwork and more defined roles provide more reliable guidelines than ever, but there is much more to do. With the number of patients in need of new therapies to tackle their rare diseases growing, we have an obligations to ensure the right therapies and responsibly given to those who need it most. Join us this July as we continue the conversation and clarify this uncertain landscape. 

Request Agenda